Leaderboards/Neurofibromatosis and Schwannoma Cases

Neurofibromatosis and Schwannoma Cases

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Victor Castro Oliden
Instituto Nacional de Enfermedades Neoplásicas
99
2
Anja Harder
University of Münster
82
3
Samuel T. Chao
Cleveland Clinic
56
4
Ahmed Mansour
Menoufia University
56
5
Hiroyuki Oishi
Komaki City Hospital
53
6
Shira Ronen
Cleveland Clinic
53
7
Prasheel Gupta
Mahatma Gandhi Institute of Medical Sciences
51
8
Suma Susan Mathews
Christian Medical College, Vellore
51
9
Abu Huraira Bin Gulzar
Services Institute of Medical Sciences
51
10
Kazuo Saita
Saitama Medical University
51

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Ken Porche
Mayo Clinic
99
2
David Suster
Rutgers, The State University of New Jersey
61
3
Manwi Singh
Yale University
53
4
L Hamza
Université Ibn Zohr
53
5
Daniel Tippner
Martin Luther University Halle-Wittenberg
53
6
Ahmed Siddig Elhadi
Universitas Islam Negeri Maulana Malik Ibrahim
53
7
Tabea I. Hartung
Universität Hamburg
53
8
N. E. Voinov
Federal Almazov North-West Medical Research Centre
50
9
A. V. Gorodnina
Russian Scientific Research Neurosurgical Institute
50
10
L Gonzalez Castro
Dana-Farber Cancer Institute
50

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Judith V.M.G. Bovée
Leiden University Medical Center
99
2
Miriam J. Smith
Manchester Academic Health Science Centre
99
3
Christopher P. Ames
Neurological Surgery
91
4
Pietro Mortini
Vita-Salute San Raffaele University
90
5
Marco Giovannini
House Clinic
85
6
Scott R. Plotkin
Massachusetts General Hospital
84
7
Christopher D.�M. Fletcher
Brigham and Women's Hospital
83
8
Pia Vahteristo
University of Helsinki
79
9
Werner Paulus
Institute of Neuroimmunology of the Slovak Academy of Sciences
77
10
Robert J. Stokroos
Unknown
76

All-Time Leaders Papers

1
mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma
Neuro-Oncology|2014
78 cit.
2
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
British Journal of Cancer|2018
61 cit.
3
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
Oncogenesis|2018
57 cit.
4
Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
BMC Cancer|2012
43 cit.
5
Validating Immunohistochemical Staining for KIT (CD117)
American Journal of Clinical Pathology|2003
43 cit.
6
Targeting survivin as a potential new treatment for chondrosarcoma of bone
Oncogenesis|2016
34 cit.
7
Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line
Laboratory Investigation|2016
34 cit.
8
Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status
Cancers|2019
31 cit.
9
Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option
Molecular Cancer|2010
28 cit.
10
Supplementary Materials from Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2
Unknown Journal|2023
0 cit.

Reagents for Neurofibromatosis and Schwannoma Cases

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

Neurofibromin 1 (D7R7D) Rabbit Monoclonal Antibody

Cited in 8 papers
#14623$161
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

Active Rho Detection Kit

Cited in 6 papers
#8820$1,035
View Evidence →Cell Signaling Technology

Torin 1

Cited in 5 papers
#14379$210
View Evidence →Agilent/Dako

CD 117 (c-Kit, SCF-Receptor)

Cited in 5 papers
#A4502
View Evidence →

🌟 All-Time

Most validated

Millipore

Anti-Histone H3.3 Antibody, K27M mutant

Cited in 10 papers
#ABE419
View Evidence →Cell Signaling Technology

Neurofibromin 1 (D7R7D) Rabbit Monoclonal Antibody

Cited in 8 papers
#14623$161
View Evidence →Cell Signaling Technology

PathScan® Total Stat3 Sandwich ELISA Kit

Cited in 7 papers
#7305$661
View Evidence →